前列腺癌基因核酸扩增测试系统
PMA编号：P100033 · 2020-07-21
广告
决定日期2020-07-21
PMA 编号P100033
产品代码OYM
设备分类第3类
医疗专科U
咨询委员会PA
请注意，由于您没有提供具体的医疗设备监管文本，我无法提供准确的翻译。如果您能提供具体的文本内容，我将能够为您提供准确的翻译。
器械摘要
Prostrate cancer genes nucleic acid amplification test system is the device name listed in this FDA 510(k) record. The listed applicant is Gen-Probe Incorporated. It received FDA 510(k) clearance on 2020-07-21. The device is classified under product code OYM. It was reviewed by the PA advisory panel.
常见问题
What is the Prostrate cancer genes nucleic acid amplification test system?
Prostrate cancer genes nucleic acid amplification test system is a medical device that received FDA 510(k) clearance on 2020-07-21. The listed applicant is Gen-Probe Incorporated.
When did Prostrate cancer genes nucleic acid amplification test system receive FDA 510(k) clearance?
The clearance date for Prostrate cancer genes nucleic acid amplification test system can be found in the official FDA records.
Who is the listed applicant for Prostrate cancer genes nucleic acid amplification test system?
The FDA 510(k) record lists Gen-Probe Incorporated as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Prostrate cancer genes nucleic acid amplification test system?
The FDA product code for Prostrate cancer genes nucleic acid amplification test system is OYM.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告